Evidence map›Paper›PMID 32576964›Full record

ArticleLeukemia2021

Male predominance in AML is associated with specific preleukemic mutations.

Aviv De-Morgan, Manja Meggendorfer, Claudia Haferlach, Liran Shlush

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Article
  3. The global epidemiology of acute myeloid leukaemia.Nature reviews. Clinical oncology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  8. Article
  9. Review
  10. Sex-Based Differences in Risk of Therapy-Related Myeloid Neoplasms.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. High GLI-1 Expression is a Reliable Indicator of Bad Prognosis in Newly Diagnosed Acute Leukemia Patients.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aviv De-MorganDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Manja MeggendorferMLL Munich Leukemia Laboratory, Munich, Germany.
Claudia HaferlachMLL Munich Leukemia Laboratory, Munich, Germany.
Liran ShlushDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel. liran.shlush@weizman.ac.il.ORCID http://orcid.org/0000-0002-3700-270X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Databases, FactualMutationAdultBiomarkers, TumorFemaleFollow-Up StudiesHumansLeukemia, Myeloid, AcuteMaleMyelodysplastic SyndromesPreleukemiaPrognosisSex FactorsBiomarkers, Tumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.